Controller

Literature Library

Clinical Data

Support

The versatile Xoft® Axxent® Electronic Brachytherapy (eBx®) System® utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy tissue.

The Xoft System is FDA cleared, CE marked, and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including early-stage breast cancer, non-melanoma skin cancer, and gynecological cancers. Indications currently under investigation include prostate, pancreatic, colorectal and brain cancers.

The comprehensive capabilities of the Axxent controller offer an attractive option to physicians and patients for improved flexibility, precision and personalization in the targeted treatment of cancer.

CONNECT

©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.  Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.